YUGANDHAR MUNNANGI: Open Payments
NPI 1316913932 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,457 in 167 payments from 12 companies in 2025. Trend: 2023 $58,000 · 2024 $57,077 · 2025 $45,457
Speaker / faculty: $37,675Food & beverage: $4,364Travel & lodging: $2,851Consulting: $460Education: $107
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 39 | $16,179 |
| Otsuka America Pharmaceutical, Inc. | 23 | $13,940 |
| Janssen Pharmaceuticals, Inc | 21 | $13,365 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $551 |
| ABBVIE INC. | 36 | $439 |
| E.R. Squibb & Sons, L.L.C. | 15 | $290 |
| Alkermes, Inc. | 5 | $274 |
| Neurocrine BioSciences, Inc. | 5 | $185 |
| Axsome Therapeutics, Inc. | 1 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
Products named: AUSTEDO XR, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, COBENFY, UZEDY, LYBALVI.
Industry payments across NY — which companies pay providers there.
